NCT03559920View on ClinicalTrials.gov

The Optimal Dose of Sevoflurane Via Anaconda® in Post-operative Patient Underwent Head & Neck Surgery

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Patients Who Needs Sedation After Head & Neck Surgery
Interventions
DRUG

Sedate using sevoflurane via anesthetic conserving device(ACD, Anaconda®) after surgery

The investigators sedate the patients in the ICU for several days after head \& neck surgery using sevoflurane via anesthetic conserving device in sevoflurane group.

DRUG

Sedate using propofol.

Retrospectively, the investigators compare the sevoflurane group with intravenous sedation group using propofol.

Trial Locations (1)

03722

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03559920 - The Optimal Dose of Sevoflurane Via Anaconda® in Post-operative Patient Underwent Head & Neck Surgery | Biotech Hunter | Biotech Hunter